Delisting riskPopularity #4,282
Quince Therapeutics (QNCX)
Develops inhaled sirolimus for pulmonary hypertension and bronchiolitis obliterans syndrome.
$29.49
vs last close−1.86 (−5.94%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 49 days
EPS estimate
−$1.31
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$56.00−$68.00−$68.00−$50.00−$3.50$75.60−$12.31Pending
Estimate−$38.00−$48.00−$56.00−$40.00−$3.59−$26.00−$28.02−$1.31
Surprise−47.4%−41.7%−21.4%−25.0%+2.6%+390.8%+56.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$3.69 | — | — |
| Sep 2028 | −$3.57 | — | — |
| Jun 2028 | −$3.44 | — | — |
| Mar 2028 | −$3.32 | — | — |
| Dec 2027 | −$1.50 | — | — |
| Sep 2027 | −$1.50 | — | — |
| Jun 2027 | −$1.51 | — | — |
| Mar 2027 | −$1.60 | — | — |
| Dec 2026 | −$1.08 | — | — |
| Nov 2026 | −$1.31 | — | — |
| Aug 2026 | −$28.02 | −$12.31 | +56.1% |
| May 2026 | −$26.00 | $75.60 | +390.8% |
| Apr 2026 | −$3.59 | −$3.50 | +2.6% |
| Nov 2025 | −$40.00 | −$50.00 | −25.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$3.69 | — | — | $76.0M | — | — | — |
| Sep 2028 | −$3.57 | — | — | $73.1M | — | — | — |
| Jun 2028 | −$3.44 | — | — | $73.1M | — | — | — |
| Mar 2028 | −$3.32 | — | — | $70.2M | — | — | — |
| Dec 2027 | −$1.50 | — | — | $3.3M | — | — | — |
| Sep 2027 | −$1.50 | — | — | $3.1M | — | — | — |
| Jun 2027 | −$1.51 | — | — | $3.1M | — | — | — |
| Mar 2027 | −$1.60 | — | — | $3.0M | — | — | — |
| Dec 2026 | −$1.08 | — | — | $0 | — | — | — |
| Nov 11, 2026 | −$1.31 | — | — | $0 | — | — | — |
| Aug 14, 2026 | −$28.02 | −$12.31 | +56.1% | — | — | — | +5.0% |
| May 12, 2026 | −$26.00 | $75.60 | +390.8% | — | — | — | +1.6% |
| Apr 6, 2026 | −$3.59 | −$3.50 | +2.6% | — | — | — | −11.6% |
| Nov 12, 2025 | −$40.00 | −$50.00 | −25.0% | — | — | — | −4.5% |
| Aug 11, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| Jun 12, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |